Efficient immune response requires activation of CD4 and CD8 T lymphocytes and activation of tumor-infiltrating cytotoxic T lymphocytes is correlated with improved survival in cervical, endometrial, ovarian, pancreatic and colorectal cancers [20–24]. This evidence concerns the gene CD4 and neoplasm.